Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
June 3, 2024 Comments Off
Nearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their cancer returning at the 2½-year mark.
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Nearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their cancer returning at the 2½-year mark.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender